NaturesPlus T-MALE Testosterone Support Supplement Recalled for Ingredient Mismatch
NaturesPlus T-MALE liquid supplement is being recalled because the product is missing the key ingredient TongKat Ali and contains an additional ingredient, Rhodiola Rosea, that should not be present.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall for an ingredient mismatch with no reported illnesses or injuries. The actual product formulation does not match the label, and the hazard remains theoretical. FDA Class III recalls without reported harm typically score 1 or 2; ingredient and labeling errors score as Moderate (2).
Plain-English summary
NaturesPlus T-MALE Liquid Testosterone Support for Men is being recalled from the US market and international locations. The recalled products include the 8 oz and 30 oz bottle sizes distributed nationwide in the United States as well as Germany, Trinidad, Bermuda, Africa, Greece, and Panama, with 11,496 bottles affected.
The product is missing the ingredient TongKat Ali and contains additional Rhodiola Rosea, which should not be present. This represents a formulation error where the actual product contents do not match the labeled ingredients.
The recalled 30 oz bottles carry Lot Number 1379944 with expiration date 02/26 (UPC: 0 97467 48711 6). The recalled 8 oz bottles carry Lot Number 1380176 with expiration date 02/26 (UPC: 0 97467 48715 4). The manufacturer is Natural Organics, Inc.
Consumers who have purchased this product should stop using it immediately and discard it.
The recalled product
- Product
- NaturesPlus T-MALE Liquid Testosterone Support for Men 8 OZ Berry and 30 OZ Berry
- Manufacturer
- Natural Organics, Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- mis-labeling
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27